Liver Diseases  >>  insulin peglispro (LY2605541)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
insulin peglispro (LY2605541) / Eli Lilly
NCT01751399: A Single Dose Study of LY2605541 in Participants With Liver Impairment

Completed
1
35
Europe
LY2605541
Eli Lilly and Company
Healthy Volunteers, Hepatic Insufficiency, Diabetes Mellitus, Type 2
09/13
09/13

Download Options